<DOC>
	<DOC>NCT00215423</DOC>
	<brief_summary>The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug</brief_summary>
	<brief_title>Study in Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Diagnosis of COPD History of cigarette smoking Clinical diagnosis of asthma Significant pulmonary disease other than COPD Other significant major organ disease(s)</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Formoterol Fumarate</keyword>
	<keyword>Formoterol</keyword>
</DOC>